Candriam SCA’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.62M | Sell |
850,454
-63
| -0% | -$268 | 0.02% | 406 |
|
|
2025
Q1 | $3.2M | Sell |
850,517
-701,045
| -45% | -$2.64M | 0.02% | 414 |
|
|
2024
Q4 | $9.05M | Buy |
1,551,562
+44,798
| +3% | +$261K | 0.05% | 277 |
|
|
2024
Q3 | $18M | Buy |
1,506,764
+448,091
| +42% | +$5.35M | 0.1% | 196 |
|
|
2024
Q2 | $11.5M | Buy |
1,058,673
+705,655
| +200% | +$7.63M | 0.07% | 238 |
|
|
2024
Q1 | $4M | Buy |
353,018
+138,010
| +64% | +$1.56M | 0.03% | 381 |
|
|
2023
Q4 | $3.02M | Buy |
+215,008
| New | +$3.02M | 0.02% | 418 |
|
|
2022
Q1 | – | Sell |
-332,572
| Closed | -$3.11M | – | 838 |
|
|
2021
Q4 | $3.11M | Sell |
332,572
-10,000
| -3% | -$93.6K | 0.02% | 458 |
|
|
2021
Q3 | $9.44M | Sell |
342,572
-7,000
| -2% | -$193K | 0.06% | 285 |
|
|
2021
Q2 | $9.78M | Buy |
349,572
+349,559
| +2,688,915% | +$9.78M | 0.07% | 289 |
|
|
2021
Q1 | $0 | Buy |
+13
| New | – | ﹤0.01% | 816 |
|